A 53-year-old male with a past medical history significant for stage IV metastatic esophageal adenocarcinoma underwent palliative esophageal stenting for malignancy-related dysphagia. Laboratory values were significant for a hemoglobin of 10.0-11.2 g/dL (reference range: 12.0-15.0 g/dL). The medication list included therapeutic enoxaparin sodium injection for a history of prior pulmonary embolism. The patient subsequently presented with severe gastroesophageal reflux. Enoxaparin was stopped prior to esophagogastroduodenoscopy (EGD) for removal of the esophageal stent and placement of a percutaneous endoscopic gastrostomy (PEG) tube (Fig. 1) . The patient tolerated the procedure and tube feeding was accordingly advanced. One week later, the patient presented with hematochezia and a hemoglobin of 6.8 g/dL. On physical examination the abdomen was soft and non-tender, with aspiration of the PEG tube revealing blood tinged tube feeds. A repeat EGD demonstrated severe gastritis as the likely source of gastrointestinal bleeding (Fig. 2) . Patient had no documented allergies. Twice daily proton pump inhibitor and sucralfate four times per day were initiated. Bleeding is a rare complication of PEG tube placement with most bleeding controlled by local pressure. Common causes are reflux esophagitis and gastric ulcer, while less common etiologies include vascular trauma involving the gastric wall or bleeding from the stomal tract [1] [2] [3] . To date, no cases of severe gastritis after PEG tube placement have been reported. Although bleeding occurs in 1% of cases, the role of long-term enteral nutrition and the risk/benefit of PEG tube placement must be individualized.
